Wire · operational-macro

FDA grants de novo nod to handheld ER cardiac implant identifier

8 October 2026 · By Derek Watson · Wire by Fusion42

Published

8 October 2026

Topic

operational-macro

◆ Sectors

Medtech

◆ Geography

United States

◆ Source

Read at massdevice.com →

◆ Verified

Fusion42 · 10 October 2026 · Fusion42 review

BridgeSource Medical received FDA de novo clearance for its SmartRead handheld device that rapidly identifies cardiac implant brands in emergency settings, reducing delays caused by unknown or undocumented implants.

This Wire brief sits within Fusion42's coverage of Medtech.

◆ ◆ The Wire takeaway

You can now deploy FDA-cleared tech that cuts emergency triage time by identifying pacemaker brands fast. If you build medtech tools for urgent care, this approval opens new paths for device integration and hospital adoption.

◆ Coverage

1 source · 8 Oct 2026

◆ Related on Wire

◆ Topics

Medtechfda-clearancecardiac-implantemergency-carehealthtechmedtech